Biobanques tumorales et gestion des données complexes enjeux actuels et futurs

Abstract : Tumor banks are asked to clinical and translationnal research project development in oncology. They strongly participate to the assessment, then to the validation of diagnostic, prognostic and predictive biomarkers. The progressive change of these structures leads to induce a professionalization of their functioning and to identify them as key actors in oncology by the stakeholders of the public and private worlds. The progresses made in biotechnologies and therapeutics are rapidly modifying the impact and the proper functioning of the biobanks. These latter are now facing different challenges, in particular for their sustainability. Among the major issues, the integration of the clinical and biological data becoming increasingly complex leads to urgently consider an optimization of the role of different biobanks in France. Their goal is to be an attractive counterpart face to the international competition. The purpose of this review is to briefly describe the current evolution of the biobanks, then their present and future challenges, and finally the role made by the pathologists in these new issues in oncology field. © 2019 Elsevier Masson SAS
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02094608
Contributor : Laurent Jonchère <>
Submitted on : Tuesday, April 9, 2019 - 5:31:18 PM
Last modification on : Thursday, November 7, 2019 - 3:44:09 PM

Identifiers

Citation

Paul Hofman, G. Dagher, Pierre Laurent-Puig, C. Hugo-Marquette, F. Barlesi, et al.. Biobanques tumorales et gestion des données complexes enjeux actuels et futurs. Annales de Pathologie, Elsevier Masson, 2019, 39 (2), pp.137-143. ⟨10.1016/j.annpat.2019.01.017⟩. ⟨hal-02094608⟩

Share

Metrics

Record views

45